扩展性心肌病的表观遗传调节
Chia-Feng Liu1, Steven Leon2, W H Wilson Tang3
1Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic, Mail code NC10, Cleveland, OH 44195, USA; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.
Heart failure clinics
|November 20, 2025
概括
扩张性心肌病 (DCM) 涉及遗传和环境因素. 像DNA甲基化和非编码RNA这样的表观遗传机制是理解DCM病原和开发新治疗方法的关键.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 扩张性心肌病 (DCM) 是一种心肌疾病,导致收缩能力受损和心力衰竭.
- DCM有多种原因,包括遗传倾向和环境因素.
- 人们越来越认识到表观遗传机制对DCM发展至关重要.
研究的目的:
- 探索表观遗传机制在扩张性心肌病的发病过程中的作用.
- 审查DCM的家族和非遗传形式,突出遗传和环境联系.
- 确定DCM管理的潜在生物标志物和治疗目标.
主要方法:
- 关于DCM和表观遗传学的最新科学文献的综述.
- 对与基因变异相关的家族性DCM的分析 (例如,lamin A/C,titin).
- 对非遗传性DCM形式 (如糖尿病,自身免疫) 的检查.
主要成果:
- 表观遗传因素,包括DNA甲基化,基因组修饰和非编码RNA,显著调节DCM中的基因表达.
- 像lamin A/C和titin这样的基因中的致病变体与家族DCM有关.
- 环境因素有助于DCM,通过表观遗传途径与遗传倾向相互作用.
结论:
- 表观遗传机制是DCM中遗传和环境影响之间的关键联系.
- 了解这些表观遗传因素为新型诊断生物标志物提供了潜力.
- 准表观遗传通路为DCM提供了有前途的治疗策略.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
449
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Cardiomyopathy III: Hypertrophic Cardiomyopathy
378
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiomyopathy V: Interprofessional Care
316
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
Cardiomyopathy I: Introduction and Classification
483
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
483
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K


